Patients taking Chantix to help them quit smoking may find the drug a bit harder to locate as multiple lots have been recalled for possible contamination with, of all things, a probable human carcinogen.
Nine lots of varenicline (the drug name for Chantix) have been recalled by Pfizer. Most of the affected lots were still in warehouses and awaiting distribution, however, the company has halted further releases of the medication into ...
continue reading...The United States Food and Drug Administration decided to maintain the black box warning on Pfizer’s smoking cessation drug Chantix (varenicline). The drug continues to carry the very serious black box warning which was first added to the label in 2009.
In seeking the removal of the black box warning, Pfizer relied on a meta-analysis of five studies to argue there is no association between the drug and suicidal thoughts. The advisory panel nonetheless is ...
continue reading...
An analysis of clinical trials found the anti-smoking drug Chantix, manufactured by Pfizer Inc., produced a higher rate of heart attacks and strokes in patients who used the treatment compared to those who didn’t.
An FDA warning says it’s “more likely that (the increased risk) is related to the drug and not purely a chance finding.”
Of 4,190 Chantix users, Bloomberg reports, 13 were found to have experienced a major cardiovascular event ...
continue reading...
